| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8681790 | Clinical Neurology and Neurosurgery | 2018 | 30 Pages |
Abstract
CSM of fresh human brain tumor tissue provides clinically meaningful and rapid histopathological assessment much faster than frozen section. With appropriate stains, including specific cellular structure or antibody staining, CSM could improve the timeliness of intraoperative decision-making, and the neurosurgical-pathology workflow during resection of human brain tumors, ultimately improving patient care.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Nikolay L. Martirosyan, Joseph Georges, Jennifer M. Eschbacher, Evgenii Belykh, Alessandro Carotenuto, Robert F. Spetzler, Peter Nakaji, Mark C. Preul,